Clinical application of gonadotropin-releasing hormone analogs in children and adolescents
Although the increasing incidence of central precocious puberty (CPP) in Korea has recently raised public concerns about health and growth problems, there are many areas of uncertainty regarding the pathogenesis, diagnosis, and management of CPP. In this paper, we review the definition of precocity,...
Main Author: | Ho-Seong Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Pediatric Society
2010-03-01
|
Series: | Korean Journal of Pediatrics |
Online Access: | http://www.kjp.or.kr/upload/2010530303-20100419142019.PDF |
Similar Items
-
Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs
by: Maira Huerta-Reyes, et al.
Published: (2019-10-01) -
Gonadotropin-releasing hormone analogs: Understanding advantages and limitations
by: Pratap Kumar, et al.
Published: (2014-01-01) -
The Effects of gonadotropin-releasing hormone analog and a combination of gonadotropin-releasing hormone analog and recombinant human growth hormone on adult height in girls with early puberty
by: Ghodsieh Hajzadeh, et al.
Published: (2019-01-01) -
Effect of tamoxifen with or without gonadotropin-releasing hormone analog on DXA values in women with breast cancer
by: Eun Heui Kim, et al.
Published: (2021-02-01) -
Adjuvant gonadotropin releasing hormone analog in gonadotoxic chemotherapy for preservation of fertility
by: K. V. S. Hari Kumar, et al.
Published: (2013-01-01)